Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease



Rating:

Share or cite this content

Citations should be made in the following way:
B. Gonzalez Quero (Barakaldo, Spain), E. Tabernero Huguet (Barakaldo, Spain), P. Sobradillo Ecenarro (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), J. Andia Iturrate (Barakaldo, Spain), L. Garcia Echebarria (Barakaldo, Spain), M. Iriberri Pascual (Barakaldo, Spain). PREVALENCE OF NON TUBERCULOUS MYCOBACTERIA (NTM) IN HIGH RISK COPD PATIENTS. 3093

Member's Comments

No comment yet.

Related content which might interest you: SALBUTAMOL AND IPRATROPIUM BROMIDE ARE HIGH RISK FACTORS FOR ATRIAL ARRHYTHMIAS IN PATIENTS WITH COPD AND CVS DISEASES. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 COMPARISON OF PHYSICAL PERFORMANCE AND SPIROMETRY VALUES ACCORDING TO FALL RISK OF COPD SUBJECTS Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy Year: 2020 FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP) Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 BACTERIAL IMMUNOTHERAPY IN COPD AND/OR BRONCHIECTASIS FREQUENT EXACERBATOR PATIENTS. A RETROSPECTIVE STUDY. Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018 IMPROVING HOME OXIGEN THERAPY IN PATIENTS WITH INTERSTITIAL LUNG DISEASES (ILDs): APPLICATION OF A PORTABLE NON-INVASIVE VENTILATION (NIV) DEVICE Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 GLN27GLU POLYMORPHISM IN THE ß2-ADRENERGIC RECEPTOR GENE AND THE RISK OF ARTERIAL HYPERTENSION IN PATIENTS WITH BRONCHIAL ASTHMA Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients Year: 2019 RISK FACTORS FOR LONG-TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 IMMUNOLOGICAL EVENTS AND SURVIVAL IN LUNG CANCER PATIENTS WITH COPD Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 TREATMENT OF MDR-TB PATIENTS WITH DELETION POLYMORPHISM OF XENOBIOTICS DETOXICATION SYSTEM GENES OF GLUTATHIONE-S-TRANSFERASE Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 MAINTAINING PULMONARY REHABILITATION EFFECTS IN COPD PATIENTS AT HOME – A PROTOCOL STUDY Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world Year: 2020 NEBULIZER AEROSOL DRUG DELIVERY THROUGH HIGH FLOW NASAL CANNULA IN ADULT PATIENTS Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 EXTRARESPIRATORY SYMPTOM BURDEN IN PATIENTS HOSPITALIZED FOR A COPD EXACERBATION: IT’S NOT ONLY ABOUT RESPIRATORY SYMPTOMS Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 INCREASED MYOSTATIN AS A NEGATIVE REGULATOR OF MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: CLINICAL IMPLICATIONS Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation Year: 2020 LIPID PEROXIDATION IN PATIENTS WITH COPD AND CHRONIC HEART FAILURE. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 HEALTH RELATED QUALITY OF LIFE (HRQoL) AMONG PATIENTS WITH NON CYSTIC FIBROSIS BROCHIECTASIS (BE) IN STABLE PHASE Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018 RISK FACTORS FOR THE DEVELOPMENT OF SARCOPENIA IN PATIENTS WITH COVID-19 Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2021 RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES Source: Virtual Congress 2020 – COPD phenotypes Year: 2020